结论：本瘤是累及皮下脂肪组织的，具有独特临床病理特征的特殊类型的皮肤淋巴瘤。
Conclusions This tumor is a special type of skin lymphoma involving subcutaneous fat tissue and special clinicopathological features.
据NCI称，系统性alcl是一种罕见的恶性肿瘤(非霍奇金淋巴瘤)，可见于身体多个部位，包括淋巴结、皮肤、骨骼、软组织、肺或肝。
Systemic ALCL is a rare malignant tumor (non-Hodgkin lymphoma) that may appear in several parts of the body including the lymph nodes, skin, bones, soft tissue, lungs or liver, according to the NCI.
目的：研究癌基因在皮肤T细胞淋巴瘤中的作用。
Objective: To study the role of the oncogenes in cutaneous t cell lymphoma.
ISTODAX被批准用于治疗皮肤t在谁得到至少有一个事先全身治疗的患者细胞淋巴瘤。
ISTODAX is indicated for treatment of cutaneous T-cell lymphoma in patients who have received at least one prior systemic therapy.
诊断为原发性皮肤间变性大细胞淋巴瘤。
The pathologic diagnosis was primary cutaneous anaplastic large cell lymphoma.
并将各亚型与皮肤B细胞性假性淋巴瘤及组织细胞性淋巴瘤进行鉴别。
Differential diagnosis of CBCL between cutaneous B-cell pseudolymphoma and cutaneous genuine histiocytic lymphoma is discussed.
结论：SPTCL在儿童皮肤非何杰金淋巴瘤中并不少见。
Conclusion: SPTCL is not rare in cutaneous non-Hodgkin's lymphoma in children.
2011年前诺华公司想要发布的其他药物是治疗非小细胞肺癌的ASA404，治疗一种罕见消化系统神经内分泌癌的SOM230和治疗皮肤T细胞淋巴瘤的LBH589。
Others drugs Novartis aims to launch by 2011 are ASA404 for non-small-cell lung cancer, SOM230 for a rare group of neuroendocrine tumors and LBH589 for cutaneous T-cell lymphoma.
临床研究表明，FK228可对多种肿瘤产生作用，对皮肤t -细胞淋巴瘤及耐药性肿瘤的疗效尤为显著。
The clinical researches showed that FK228 is effective against different tumors, especially against Cutaneous T-Cell Lymphoma and drug resistance tumors.
目的：探讨原发性皮肤间变性大细胞淋巴瘤(C - ALCL)临床病理特点和基因诊断方法。
Objective: To explore the clinicopathological features of primary cutaneous anaplastic large cell lymphoma (C-ALCL) and the significance of genetic analysis in the diagnosis.
报告1例alk - 1蛋白阳性的原发性皮肤CD 30 +间变性大细胞淋巴瘤。
A case of primary cutaneous CD30-positive anaplastic large cell lymphoma with ALK-1 positive is reported.
皮损组织病理及免疫组化标记确诊为原发性皮肤CD 30 +间变性大细胞淋巴瘤。
The diagnosis of primary cutaneous CD30 + anaplastic large cell lymphoma was established by means of histopathology and immunohistochemistry.
细胞受体基因重排的检测在皮肤T细胞淋巴瘤的发病机制研究、分类、诊断、判断预后上有重要的作用。
The detection of TCR gene rearrangement has an important role in the study of the pathogenesis, classification, diagnosis and monitoring of prognosis of CTCL.
抗肿瘤药罗米地辛是一种有效的组蛋白去乙酰化酶抑制剂，临床 上用于治疗皮肤T细胞淋巴瘤。
Romidepsin is a potent histone deacetylase inhibitor, and is used in the treatment of cutaneous T-cell lymphoma (CTCL).
方法对8例淋巴结及皮肤的间变性大细胞淋巴瘤组织学观察及免疫组化染色，并复习相关临床资料。
Methods: Histological and immunohistochemical methods were used to analyse 8 cases of ALCL located in the skin and in the lymphoid node, and the correlated clinical data were reviewed.
皮肤T细胞淋巴瘤是一种名为t -淋巴细胞的抗感染白细胞缓慢生长的癌症。
Cutaneous T-cell lymphoma is a slow-growing cancer of infection-fighting white blood cells called T-lymphocytes.
蕈样霉菌病（MF）是最常见的皮肤原发性T细胞淋巴瘤，约10%的病例可发生转化。
Mycosis fungoides (MF), the most common primitive cutaneous T-cell lymphoma, can undergo transformation in about 10% of cases.
蕈样霉菌病（MF）是最常见的皮肤原发性T细胞淋巴瘤，约10%的病例可发生转化。
Mycosis fungoides (MF), the most common primitive cutaneous T-cell lymphoma, can undergo transformation in about 10% of cases.
应用推荐